BioNTech
Founded 2008 · 5,212 employees on LinkedIn · 5 known investors
Find your way into BioNTech
Sign up to find every way you can get introduced to BioNTech
- Your email: who you already know at BioNTech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BioNTech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
BioNTech develops immunotherapies that use the body's immune system to treat cancer, infectious diseases, and other serious illnesses. The company combines novel therapeutic modalities with a range of biological targets across multiple indication areas.
Founders & leadership
Investors · 5
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BSep 2019Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does BioNTech do?
- BioNTech develops immunotherapies that use the body's immune system to treat cancer, infectious diseases, and other serious illnesses. The company combines novel therapeutic modalities with a range of biological targets across multiple indication areas.
- Who are BioNTech's investors?
- BioNTech's investors include HM Venture Partners, Pfizer Venture Investments, Salvia, Andreessen Horowitz, MIG Capital AG.

